Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs AME✓SelectedUSD · AMEGSK vs AME performance historyLatest closeAs of-1.34%11/18
Stock and ETF performance explorer

GSK vs AME

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+55.4%
AME return
+54.1%
Excess return
+1.3%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioAMEExcessAlpha
1D-1.3%+0.3%-1.7%-1.4%
7D-3.1%-1.7%-1.4%-3.0%
30D-0.9%-4.7%+3.8%-0.7%
3M-4.2%-5.6%+1.4%-3.9%
6M-1.6%+4.7%-6.3%-3.0%
YTD+2.6%+15.3%-12.7%-0.1%
1Y+6.2%+24.8%-18.6%+2.6%
All+55.4%+54.1%+1.3%+41.3%

Cumulative growth

Daily Returns

Daily percentage return beside AME.

Daily Out/Under-Performance

Portfolio return minus AME return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × AME return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded AME wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling